The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
Open accessAbstract
OBJECTIVE: To provide estimates of the relative rate of COVID-19 death in people <65 years old versus older individuals in the general population, the absolute risk of COVID-19 death at the population level during the first epidemic wave, and the proportion of COVID-19 deaths in non-elderly people without underlying diseases in epicenters of the pandemic. ELIGIBLE DATA: Cross-sectional survey of countries and US states with at least 800 COVID-19 deaths as of April 24, 2020 and with information on the number of deaths in people with age <65. Data were available for 14 countries (Belgium, Canada, France, Germany, India, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, UK) and 13 US states (California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, New Jersey, New York, Pennsylvania). We also examined available data on COVID-19 deaths in people with age <65 and no underlying diseases. MAIN OUTCOME MEASURES: Proportion of COVID-19 deaths in people <65 years old; relative mortality rate of COVID-19 death in people <65 versus ≥65 years old; absolute risk of COVID-19 death in people <65 and in those ≥80 years old in the general population as of June 17, 2020; absolute COVID-19 mortality rate expressed as equivalent of mortality rate from driving a motor vehicle. RESULTS: Individuals with age <65 account for 4.5-11.2% of all COVID-19 deaths in European countries and Canada, 8.3-22.7% in the US locations, and were the majority in India and Mexico. People <65 years old had 30- to 100-fold lower risk of COVID-19 death than those ≥65 years old in 11 European countries and Canada, 16- to 52-fold lower risk in US locations, and less than 10-fold in India and Mexico. The absolute risk of COVID-19 death as of June 17, 2020 for people <65 years old in high-income countries ranged from 10 (Germany) to 349 per million (New Jersey) and it was 5 per million in India and 96 per million in Mexico. The absolute risk of COVID-19 death for people ≥80 years old ranged from 0.6 (Florida) to 17.5 per thousand (Connecticut). The COVID-19 mortality rate in people <65 years old during the period of fatalities from the epidemic was equivalent to the mortality rate from driving between 4 and 82 miles per day for 13 countries and 5 states, and was higher (equivalent to the mortality rate from driving 106-483 miles per day) for 8 other states and the UK. People <65 years old without underlying predisposing conditions accounted for only 0.7-3.6% of all COVID-19 deaths in France, Italy, Netherlands, Sweden, Georgia, and New York City and 17.7% in Mexico. CONCLUSIONS: People <65 years old have very small risks of COVID-19 death even in pandemic epicenters and deaths for people <65 years without underlying predisposing conditions are remarkably uncommon. Strategies focusing specifically on protecting high-risk elderly individuals should be considered in managing the pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674 · cited 1×
“Moreover, females may have approximately 2-times lower risk than males (Williamson et al., 2020).”
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Covid-19 — Navigating the Uncharted
Fauci, A. S., Lane, H. C., & Redfield, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejme2002387 · Cited by 1,969
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020) · Aging · doi:10.18632/aging.103000 · Cited by 1,304
Spread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Responding to Covid-19 — A Once-in-a-Century Pandemic?
Gates, B. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003762 · Cited by 1,076
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy
De Filippo, O., D’Ascenzo, F., Angelini, F., Bocchino, P. P., Conrotto, F., Saglietto, A., Secco, G. G., Campo, G., Gallone, G., Verardi, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009166 · Cited by 1,020
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684
Self-citationCOVID-19 antibody seroprevalence in santa clara county, california
Bendavid, E., Mulaney, B., Sood, N., Shah, S., Bromley-Dulfano, R., Lai, C., Weissberg, Z., Saavedra-Walker, R., Tedrow, J., Bogan, A., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab010 · Cited by 669
Self-citationThe Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and Costs
Yazdanyar, A., & Newman, A. B. (2009) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.07.007 · Cited by 666
Metzler, B., Siostrzonek, P., Binder, R. K., Bauer, A., & Reinstadler, S. J. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa314 · Cited by 634
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Sud, A., Jones, M. E., Broggio, J., Loveday, C., Torr, B., Garrett, A., Nicol, D. L., Jhanji, S., Boyce, S. A., Gronthoud, F., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.05.009 · Cited by 552
COVID-19 – the law and limits of quarantine
Parmet, W. E., & Sinha, M. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2004211 · Cited by 492
Wang, X., Li, Y., O'Brien, K. L., Madhi, S. A., Widdowson, M.-A., Byass, P., Omer, S. B., Abbas, Q., Ali, A., Amu, A., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30545-5 · Cited by 492
Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures
Ioannidis, J. P. A. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13222 · Cited by 364
Self-citationWhat Other Countries Can Learn From Italy During the COVID-19 Pandemic
Boccia, S., Ricciardi, W., & Ioannidis, J. P. A. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.1447 · Cited by 335
Self-citationSeroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Shakiba, M., Nazemipour, M., Salari, A., Mehrabian, F., Nazari, S. S. H., Rezvani, S. M., Ghasempour, Z., Heidarzadeh, A., & Mansournia, M. A. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2702.201960 · Cited by 164
Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures
Ioannidis, J. P. A. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13223 · Cited by 123
Self-citationMoser, D. A., Glaus, J., Frangou, S., & Schechter, D. S. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.56 · Cited by 88
Doi, A., Iwata, K., Kuroda, H., Hasuike, T., Nasu, S., Kanda, A., Nagao, T., Nishioka, H., Tomii, K., Morimoto, T., et al. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100747 · Cited by 77
Heart disease in the Netherlands: a quantitative update
Leening, M. J. G., Siregar, S., Vaartjes, I. C. H., Bots, M. L., Versteegh, M. I. M., van Geuns, R., Koolen, J., & Deckers, J. W. (2013) · Netherlands Heart Journal · doi:10.1007/s12471-013-0504-x · Cited by 56
Excess deaths during the Covid-19 pandemic: An international comparisonPreprint
Docherty, K. F., Butt, J. H., de Boer, R. A., Dewan, P., Køber, L., Maggioni, A. P., McMurray, J. J. V., Solomon, S. D., & Jhund, P. S. (2020) · medRxiv · doi:10.1101/2020.04.21.20073114 · Cited by 48
2015-16-american-driving-survey
Shull, E., Carney, C., Gaspar, J., Johnson‐Turbes, A., & LaRose, C. (2018) · AAA Foundation for Traffic Safety. · Cited by 19
Wittkowski, K. M. (2022) · Cureus · doi:10.7759/cureus.29146 · Cited by 11
Expressing Death Risk as Condensed Life Experience and Death Intensity
Ioannidis, J. P. A. (2013) · Medical Decision Making · doi:10.1177/0272989x13484389 · Cited by 3
Self-citation
Cited by
Infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684
Self-citationForecasting for COVID-19 has failed
Ioannidis, J. P. A., Cripps, S., & Tanner, M. A. (2022) · International Journal of Forecasting · doi:10.1016/j.ijforecast.2020.08.004 · Cited by 430
Self-citationCOVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Hagger, M. S., Smith, S. R., Keech, J. J., Moyers, S. A., & Hamilton, K. (2020) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa073 · Cited by 196
Should governments continue lockdown to slow the spread of covid-19?
Melnick, E. R., & Ioannidis, J. P. A. (2020) · BMJ · doi:10.1136/bmj.m1924 · Cited by 104
Self-citation
Metadata
- Authors
- Ioannidis, J. P. A., Axfors, C., & Contopoulos-Ioannidis, D. G.
- Venue
- Environmental Research
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 188
- Pages
- 109890
- ISSN
- 0013-9351 (ISSN-L)
- OpenAlex
- W3039338904
- Cited by
- 331
- References
- 28
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.